Scope Fluidics S.A. (WSE:SCP)
121.20
+1.00 (0.83%)
Jul 6, 2026, 5:00 PM CET
Scope Fluidics Market Cap
Scope Fluidics has a market cap or net worth of 380.83 million as of July 6, 2026. Its market cap has decreased by -6.24% in one year.
Market Cap
380.83M
Enterprise Value
244.89M
Revenue
104.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
121.20
Market Cap Chart
Since August 16, 2017, Scope Fluidics's market cap has increased from 41.31M to 380.83M, an increase of 821.78%. That is a compound annual growth rate of 28.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 380.83M | -11.75% |
| Dec 30, 2025 | 431.52M | -3.47% |
| Dec 30, 2024 | 447.05M | -16.33% |
| Dec 29, 2023 | 534.28M | -5.54% |
| Dec 30, 2022 | 565.63M | 54.38% |
| Dec 30, 2021 | 366.40M | 1.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.13B |
| NEUCA | 3.20B |
| Synektik Spólka Akcyjna | 3.08B |
| Voxel | 1.21B |
| Bioceltix | 496.24M |
| Mercator Medical | 476.42M |
| Captor Therapeutics Spolka Akcyjna | 475.23M |
| Syn2bio | 427.90M |